China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 2.31
(-0.86%)
HKD 2.31
(-0.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.42 Billion CNY | 34.11% |
| 2022 | 1.06 Billion CNY | -61.34% |
| 2021 | 2.75 Billion CNY | 10.54% |
| 2020 | 2.49 Billion CNY | 1.22% |
| 2019 | 2.46 Billion CNY | 14.13% |
| 2018 | 2.15 Billion CNY | 20.69% |
| 2017 | 1.78 Billion CNY | 24.47% |
| 2016 | 1.43 Billion CNY | 89.91% |
| 2015 | 755.74 Million CNY | 38.57% |
| 2014 | 545.39 Million CNY | 99.95% |
| 2013 | 272.75 Million CNY | 16.88% |
| 2012 | 233.35 Million CNY | 182.28% |
| 2011 | 82.66 Million CNY | -18.53% |
| 2010 | 101.46 Million CNY | 20.31% |
| 2009 | 84.33 Million CNY | 74.84% |
| 2008 | 48.23 Million CNY | 50.72% |
| 2007 | 32 Million CNY | 6591.51% |
| 2006 | 478.28 Thousand CNY | 100.06% |
| 2005 | -839.83 Million CNY | -1576.05% |
| 2004 | -50.1 Million CNY | -345.54% |
| 2003 | 20.4 Million CNY | -85.59% |
| 2002 | 141.64 Million CNY | 54.87% |
| 2001 | 91.46 Million CNY | 54.46% |
| 2000 | 59.21 Million CNY | -74.76% |
| 1999 | 234.61 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 192.29 Million CNY | -37.29% |
| 2024 Q2 | 192.29 Million CNY | 0.0% |
| 2023 Q1 | 391.64 Million CNY | 23.45% |
| 2023 Q3 | 282.68 Million CNY | -27.82% |
| 2023 FY | 1.42 Billion CNY | 34.11% |
| 2023 Q4 | 306.61 Million CNY | 8.46% |
| 2023 Q2 | 391.64 Million CNY | 0.0% |
| 2022 Q2 | 270.22 Million CNY | 0.0% |
| 2022 Q1 | 270.22 Million CNY | -61.6% |
| 2022 FY | 1.06 Billion CNY | -61.34% |
| 2022 Q4 | 317.25 Million CNY | 0.0% |
| 2022 Q3 | 317.25 Million CNY | 17.4% |
| 2021 Q3 | 703.67 Million CNY | 8.11% |
| 2021 Q4 | 703.67 Million CNY | 0.0% |
| 2021 FY | 2.75 Billion CNY | 10.54% |
| 2021 Q1 | 650.89 Million CNY | -6.12% |
| 2021 Q2 | 650.89 Million CNY | 0.0% |
| 2020 FY | 2.49 Billion CNY | 1.22% |
| 2020 Q3 | 693.34 Million CNY | 27.55% |
| 2020 Q2 | 543.57 Million CNY | 0.0% |
| 2020 Q4 | 693.34 Million CNY | 0.0% |
| 2020 Q1 | 543.57 Million CNY | -9.13% |
| 2019 Q4 | 598.2 Million CNY | 0.0% |
| 2019 Q2 | 617.04 Million CNY | 0.0% |
| 2019 Q1 | 617.04 Million CNY | 22.13% |
| 2019 FY | 2.46 Billion CNY | 14.13% |
| 2019 Q3 | 598.2 Million CNY | -3.05% |
| 2018 Q4 | 505.22 Million CNY | 0.0% |
| 2018 FY | 2.15 Billion CNY | 20.69% |
| 2018 Q3 | 505.22 Million CNY | -7.41% |
| 2018 Q2 | 545.64 Million CNY | 0.0% |
| 2018 Q1 | 545.64 Million CNY | 24.18% |
| 2017 FY | 1.78 Billion CNY | 24.47% |
| 2017 Q4 | 439.37 Million CNY | 0.0% |
| 2017 Q1 | 441.3 Million CNY | 46.3% |
| 2017 Q3 | 439.37 Million CNY | -0.44% |
| 2017 Q2 | 441.3 Million CNY | 0.0% |
| 2016 Q1 | 340.88 Million CNY | 105.25% |
| 2016 FY | 1.43 Billion CNY | 89.91% |
| 2016 Q4 | 301.63 Million CNY | 0.0% |
| 2016 Q3 | 301.63 Million CNY | -11.52% |
| 2016 Q2 | 340.88 Million CNY | 0.0% |
| 2015 Q4 | 166.08 Million CNY | 0.0% |
| 2015 Q1 | 143.97 Million CNY | -1.64% |
| 2015 FY | 755.74 Million CNY | 38.57% |
| 2015 Q2 | 143.97 Million CNY | 0.0% |
| 2015 Q3 | 166.08 Million CNY | 15.36% |
| 2014 Q4 | 146.36 Million CNY | 0.0% |
| 2014 FY | 545.39 Million CNY | 99.95% |
| 2014 Q3 | 146.36 Million CNY | 12.45% |
| 2014 Q2 | 130.16 Million CNY | 0.0% |
| 2014 Q1 | 130.16 Million CNY | 54.41% |
| 2013 Q2 | 43.13 Million CNY | 0.0% |
| 2013 Q4 | 84.3 Million CNY | 0.0% |
| 2013 Q3 | 84.3 Million CNY | 95.44% |
| 2013 FY | 272.75 Million CNY | 16.88% |
| 2013 Q1 | 43.13 Million CNY | -31.47% |
| 2012 Q1 | 57.22 Million CNY | 0.0% |
| 2012 Q2 | 57.22 Million CNY | 0.0% |
| 2012 Q3 | 62.57 Million CNY | 9.34% |
| 2012 Q4 | 62.94 Million CNY | 0.59% |
| 2012 FY | 233.35 Million CNY | 182.28% |
| 2011 Q1 | 18.78 Million CNY | 0.0% |
| 2011 FY | 82.66 Million CNY | -18.53% |
| 2011 Q4 | 57.22 Million CNY | 204.72% |
| 2011 Q3 | 18.78 Million CNY | 0.0% |
| 2011 Q2 | 18.78 Million CNY | 0.0% |
| 2010 Q4 | 18.78 Million CNY | -2.14% |
| 2010 FY | 101.46 Million CNY | 20.31% |
| 2010 Q3 | 19.19 Million CNY | 0.0% |
| 2010 Q1 | 19.19 Million CNY | 0.0% |
| 2010 Q2 | 19.19 Million CNY | 0.0% |
| 2009 Q3 | 14.59 Million CNY | 0.0% |
| 2009 Q1 | 14.59 Million CNY | 0.0% |
| 2009 Q2 | 14.59 Million CNY | 0.0% |
| 2009 Q4 | 19.19 Million CNY | 31.52% |
| 2009 FY | 84.33 Million CNY | 74.84% |
| 2008 Q1 | 5.56 Million CNY | 0.0% |
| 2008 FY | 48.23 Million CNY | 50.72% |
| 2008 Q4 | 14.59 Million CNY | 162.34% |
| 2008 Q3 | 5.56 Million CNY | 0.0% |
| 2008 Q2 | 5.56 Million CNY | 0.0% |
| 2007 Q3 | 7.7 Million CNY | 0.0% |
| 2007 Q4 | 5.56 Million CNY | -27.83% |
| 2007 FY | 32 Million CNY | 6591.51% |
| 2007 Q1 | 7.7 Million CNY | 0.0% |
| 2007 Q2 | 7.7 Million CNY | 0.0% |
| 2006 Q1 | -108.08 Million CNY | 0.0% |
| 2006 FY | 478.28 Thousand CNY | 100.06% |
| 2006 Q4 | 7.7 Million CNY | 107.13% |
| 2006 Q3 | -108.08 Million CNY | 0.0% |
| 2006 Q2 | -108.08 Million CNY | 0.0% |
| 2005 Q2 | -214.78 Million CNY | 0.0% |
| 2005 Q4 | -108.08 Million CNY | 49.68% |
| 2005 Q3 | -214.78 Million CNY | 0.0% |
| 2005 Q1 | -214.78 Million CNY | 0.0% |
| 2005 FY | -839.83 Million CNY | -1576.05% |
| 2004 Q2 | -16.86 Million CNY | 0.0% |
| 2004 Q3 | -16.86 Million CNY | 0.0% |
| 2004 Q4 | -214.78 Million CNY | -1173.74% |
| 2004 FY | -50.1 Million CNY | -345.54% |
| 2004 Q1 | -16.86 Million CNY | 0.0% |
| 2003 Q1 | -3.24 Million CNY | 0.0% |
| 2003 FY | 20.4 Million CNY | -85.59% |
| 2003 Q4 | -16.86 Million CNY | -418.96% |
| 2003 Q2 | -3.24 Million CNY | 0.0% |
| 2003 Q3 | -3.24 Million CNY | 0.0% |
| 2002 Q2 | 20.45 Million CNY | 0.0% |
| 2002 Q3 | 20.45 Million CNY | 0.0% |
| 2002 FY | 141.64 Million CNY | 54.87% |
| 2002 Q4 | -3.24 Million CNY | -115.88% |
| 2002 Q1 | 20.45 Million CNY | 0.0% |
| 2001 Q2 | 22.86 Million CNY | 0.0% |
| 2001 Q1 | 22.86 Million CNY | 0.0% |
| 2001 FY | 91.46 Million CNY | 54.46% |
| 2001 Q4 | 20.45 Million CNY | -10.53% |
| 2001 Q3 | 22.86 Million CNY | 0.0% |
| 2000 Q2 | 12.8 Million CNY | 0.0% |
| 2000 Q1 | 12.8 Million CNY | 0.0% |
| 2000 FY | 59.21 Million CNY | -74.76% |
| 2000 Q4 | 22.86 Million CNY | 78.53% |
| 2000 Q3 | 12.8 Million CNY | 0.0% |
| 1999 Q2 | 55 Million CNY | 0.0% |
| 1999 Q3 | 55 Million CNY | 0.0% |
| 1999 Q4 | 12.8 Million CNY | -76.71% |
| 1999 FY | 234.61 Million CNY | 0.0% |
| 1999 Q1 | 55 Million CNY | 0.0% |
| 1998 Q4 | 55 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 143.01 Million HKD | -898.012% |
| Grand Pharmaceutical Group Limited | 2.66 Billion HKD | 46.411% |
| Extrawell Pharmaceutical Holdings Limited | -8.16 Million HKD | 17586.854% |
| Wai Yuen Tong Medicine Holdings Limited | 40.88 Million HKD | -3391.382% |
| Qianhai Health Holdings Limited | -52.18 Million HKD | 2835.138% |
| Lee's Pharmaceutical Holdings Limited | 36.04 Million HKD | -3860.038% |
| Essex Bio-Technology Limited | 310.32 Million HKD | -359.923% |
| Tongfang Kontafarma Holdings Limited | - HKD | -Infinity% |
| PuraPharm Corporation Limited | -66.04 Million HKD | 2261.035% |
| SSY Group Limited | 1.63 Billion HKD | 12.913% |
| JBM (Healthcare) Limited | 174.2 Million HKD | -719.309% |
| Jacobson Pharma Corporation Limited | 333.12 Million HKD | -328.45% |
| China Resources Pharmaceutical Group Limited | 12.14 Billion HKD | 88.25% |